These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
||||
|
|
|
||||
|
(State or other jurisdiction of incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
||||
| Title of each class | Trading symbol(s) | Name of each exchange on which registered | ||||||
|
|
|
|
||||||
| Large accelerated filer | ☐ |
|
☒ | ||||||||
|
Non-accelerated filer
|
☐ |
Smaller reporting company
|
|
||||||||
|
Emerging growth company
|
|
||||||||||
|
Page
|
|||||||||||
|
September 30,
2025 |
December 31,
2024 |
|||||||||||||
| (in millions, except share amounts which are in thousands and per share amounts) | ||||||||||||||
| Assets | ||||||||||||||
| Current assets: | ||||||||||||||
| Cash and cash equivalents | $ |
|
$ |
|
||||||||||
| Accounts receivable—net |
|
|
||||||||||||
| Prepaid expenses and other current assets |
|
|
||||||||||||
| Total current assets |
|
|
||||||||||||
| Property, equipment and software—net |
|
|
||||||||||||
| Goodwill |
|
|
||||||||||||
| Intangible assets—net |
|
|
||||||||||||
|
Deferred tax asset—noncurrent
|
|
|
||||||||||||
| Right-of-use assets |
|
|
||||||||||||
| Other assets |
|
|
||||||||||||
| Total Assets | $ |
|
$ |
|
||||||||||
| Liabilities and Stockholders’ Equity | ||||||||||||||
| Current liabilities: | ||||||||||||||
| Accounts payable | $ |
|
$ |
|
||||||||||
| Accrued expenses and other current liabilities |
|
|
||||||||||||
| Total current liabilities |
|
|
||||||||||||
| Other liabilities—noncurrent |
|
|
||||||||||||
| Total liabilities |
|
|
||||||||||||
|
Commitments and contingencies (Note 5)
|
|
|
||||||||||||
| Stockholders’ equity: | ||||||||||||||
|
Preferred stock—$
|
|
|
||||||||||||
|
Common stock—$
|
|
|
||||||||||||
| Additional paid-in capital |
|
|
||||||||||||
|
Accumulated other comprehensive loss
|
(
|
(
|
||||||||||||
| Accumulated deficit |
(
|
(
|
||||||||||||
| Total stockholders’ equity |
|
|
||||||||||||
| Total Liabilities and Stockholders’ Equity | $ |
|
$ |
|
||||||||||
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
|||||||||||||||||||||||||
|
(in millions, except per share amounts)
|
2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||||
| Revenue | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Costs and Expenses: | ||||||||||||||||||||||||||
| Cost of revenue |
|
|
|
|
||||||||||||||||||||||
| Research and development |
|
|
|
|
||||||||||||||||||||||
| Sales and marketing |
|
|
|
|
||||||||||||||||||||||
| General and administrative |
|
|
|
|
||||||||||||||||||||||
| Total costs and expenses |
|
|
|
|
||||||||||||||||||||||
|
Income from Operations
|
|
|
|
|
||||||||||||||||||||||
|
Other income, net:
|
||||||||||||||||||||||||||
| Interest income |
|
|
|
|
||||||||||||||||||||||
| Interest expense |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
|
Other gains (losses), net
|
|
|
|
(
|
||||||||||||||||||||||
|
Total other income, net
|
|
|
|
|
||||||||||||||||||||||
|
Income before income taxes
|
|
|
|
|
||||||||||||||||||||||
|
Income tax provision
|
|
|
|
|
||||||||||||||||||||||
|
Net Income (Loss)
|
$ |
|
$ |
|
$ |
|
$ |
(
|
||||||||||||||||||
|
Net Income (Loss) per Share Attributable to Common Stockholders
|
||||||||||||||||||||||||||
| Basic | $ |
|
$ |
|
$ |
|
$ |
(
|
||||||||||||||||||
| Diluted | $ |
|
$ |
|
$ |
|
$ |
(
|
||||||||||||||||||
|
Weighted-average Shares Used in Computing Net Income (Loss) per Share Attributable to Common Stockholders
|
||||||||||||||||||||||||||
| Basic |
|
|
|
|
||||||||||||||||||||||
| Diluted |
|
|
|
|
||||||||||||||||||||||
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
|||||||||||||||||||||||||
|
(in millions)
|
2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||||
| Net Income (Loss) | $ |
|
$ |
|
$ |
|
$ |
(
|
||||||||||||||||||
|
Other Comprehensive Income (Loss):
|
||||||||||||||||||||||||||
| Change in foreign currency translation |
(
|
|
|
|
||||||||||||||||||||||
|
Comprehensive Income (Loss)
|
$ |
|
$ |
|
$ |
|
$ |
(
|
||||||||||||||||||
| Common Stock | Additional Paid-in Capital |
Accumulated Other Comprehensive Income (Loss)
|
Accumulated Deficit | Stockholders’ Equity | ||||||||||||||||||||||||||||||||||
| (in millions, except share amounts which are in thousands) | Shares | Amount | ||||||||||||||||||||||||||||||||||||
|
Balance as of December 31, 2024
|
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||
| Issuance of Class A common stock upon exercise of stock options |
|
— | — | — | ||||||||||||||||||||||||||||||||||
| Issuance of Class A common stock pursuant to settlement of restricted stock units |
|
— | — | |||||||||||||||||||||||||||||||||||
| Class A common stock withheld related to net share settlement of restricted stock units |
(
|
— |
(
|
(
|
||||||||||||||||||||||||||||||||||
| Stock-based compensation |
|
|
||||||||||||||||||||||||||||||||||||
|
Other comprehensive income
|
|
|
||||||||||||||||||||||||||||||||||||
|
Net income
|
|
|
||||||||||||||||||||||||||||||||||||
|
Balance as of March 31, 2025
|
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||
| Issuance of Class A common stock upon exercise of stock options |
|
— |
|
|
||||||||||||||||||||||||||||||||||
| Issuance of Class A common stock pursuant to settlement of restricted stock units |
|
— | — | |||||||||||||||||||||||||||||||||||
| Class A common stock withheld related to net share settlement of restricted stock units |
(
|
— |
(
|
(
|
||||||||||||||||||||||||||||||||||
|
Issuance of Class A common stock under Employee Stock Purchase Plan
|
|
— |
|
|
||||||||||||||||||||||||||||||||||
| Stock-based compensation |
|
|
||||||||||||||||||||||||||||||||||||
|
Other comprehensive income
|
|
|
||||||||||||||||||||||||||||||||||||
|
Net income
|
|
|
||||||||||||||||||||||||||||||||||||
|
Balance as of June 30, 2025
|
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||
| Issuance of Class A common stock upon exercise of stock options |
|
— |
|
|
||||||||||||||||||||||||||||||||||
| Issuance of Class A common stock pursuant to settlement of restricted stock units |
|
— | — | |||||||||||||||||||||||||||||||||||
| Class A common stock withheld related to net share settlement of restricted stock units |
(
|
— |
(
|
(
|
||||||||||||||||||||||||||||||||||
| Repurchase of Class A common stock |
(
|
— |
(
|
(
|
||||||||||||||||||||||||||||||||||
| Stock-based compensation |
|
|
||||||||||||||||||||||||||||||||||||
|
Other comprehensive loss
|
(
|
(
|
||||||||||||||||||||||||||||||||||||
|
Net income
|
|
|
||||||||||||||||||||||||||||||||||||
|
Balance as of September 30, 2025
|
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||
| Common Stock | Additional Paid-in Capital | Accumulated Other Comprehensive Loss | Accumulated Deficit | Stockholders’ Equity | ||||||||||||||||||||||||||||||||||
| (in millions, except share amounts which are in thousands) | Shares | Amount | ||||||||||||||||||||||||||||||||||||
|
Balance as of December 31, 2023
|
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||
| Issuance of Class A common stock upon exercise of stock options |
|
— |
|
|
||||||||||||||||||||||||||||||||||
|
Issuance of Class A common stock pursuant to settlement of restricted stock units
|
|
— | — | |||||||||||||||||||||||||||||||||||
| Class A common stock withheld related to net share settlement of restricted stock units |
(
|
— |
(
|
(
|
||||||||||||||||||||||||||||||||||
| Stock-based compensation |
|
|
||||||||||||||||||||||||||||||||||||
|
Other comprehensive loss
|
(
|
(
|
||||||||||||||||||||||||||||||||||||
| Net income |
|
|
||||||||||||||||||||||||||||||||||||
|
Balance as of March 31, 2024
|
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||
| Issuance of Class A common stock upon exercise of stock options |
|
— |
|
|
||||||||||||||||||||||||||||||||||
| Issuance of Class A common stock pursuant to settlement of restricted stock units |
|
— | — | |||||||||||||||||||||||||||||||||||
| Class A common stock withheld related to net share settlement of restricted stock units |
(
|
— |
(
|
(
|
||||||||||||||||||||||||||||||||||
| Repurchase of Class A common stock |
(
|
— |
(
|
(
|
||||||||||||||||||||||||||||||||||
| Stock-based compensation |
|
|
||||||||||||||||||||||||||||||||||||
| Other comprehensive income |
|
|
||||||||||||||||||||||||||||||||||||
| Net loss |
(
|
(
|
||||||||||||||||||||||||||||||||||||
|
Balance as of June 30, 2024
|
|
$ |
|
$ |
|
$ |
(
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||
| Issuance of Class A common stock upon exercise of stock options |
|
— |
|
|
||||||||||||||||||||||||||||||||||
| Issuance of Class A common stock pursuant to settlement of restricted stock units |
|
— | — | |||||||||||||||||||||||||||||||||||
| Class A common stock withheld related to net share settlement of restricted stock units |
(
|
— |
(
|
(
|
||||||||||||||||||||||||||||||||||
| Repurchase of Class A common stock |
(
|
— |
(
|
(
|
||||||||||||||||||||||||||||||||||
| Stock-based compensation |
|
|
||||||||||||||||||||||||||||||||||||
|
Other comprehensive income
|
|
|
||||||||||||||||||||||||||||||||||||
|
Net income
|
|
|
||||||||||||||||||||||||||||||||||||
|
Balance as of September 30, 2024
|
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||||||||||||||
|
Nine Months Ended
September 30, |
||||||||||||||
|
(in millions)
|
2025 | 2024 | ||||||||||||
| Operating Activities: | ||||||||||||||
|
Net income (loss)
|
$ |
|
$ |
(
|
||||||||||
|
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
|
||||||||||||||
| Depreciation and amortization |
|
|
||||||||||||
| Stock-based compensation |
|
|
||||||||||||
| Deferred taxes |
|
(
|
||||||||||||
| Non-cash lease costs |
|
|
||||||||||||
|
Other losses, net
|
|
|
||||||||||||
| Changes in operating assets and liabilities: | ||||||||||||||
| Accounts receivable |
(
|
(
|
||||||||||||
| Prepaid expenses and other assets |
(
|
|
||||||||||||
|
Mortgage loans held for sale
|
(
|
|
||||||||||||
| Accounts payable |
|
|
||||||||||||
| Accrued expenses and other current liabilities |
|
|
||||||||||||
| Operating lease liabilities |
(
|
(
|
||||||||||||
| Other liabilities |
|
|
||||||||||||
|
Net cash provided by operating activities
|
|
|
||||||||||||
| Investing Activities: | ||||||||||||||
|
Purchase of investments
|
(
|
(
|
||||||||||||
| Capitalized software development costs |
(
|
(
|
||||||||||||
| Purchase of property and equipment |
(
|
(
|
||||||||||||
|
Business combination
|
(
|
|
||||||||||||
| Net cash used in investing activities |
(
|
(
|
||||||||||||
| Financing Activities: | ||||||||||||||
|
Net borrowing on warehouse line of credit
|
|
|
||||||||||||
| Proceeds from exercise of stock options |
|
|
||||||||||||
| Tax payments related to net-share settlements on restricted stock units |
(
|
(
|
||||||||||||
|
Issuance of Class A common stock under Employee Stock Purchase Plan
|
|
|
||||||||||||
|
Repurchase of Class A common stock
|
(
|
(
|
||||||||||||
|
Net cash used in financing activities
|
(
|
(
|
||||||||||||
|
Effect of exchange rate changes on cash and cash equivalents
|
(
|
|
||||||||||||
|
Net increase (decrease) in cash and cash equivalents
|
|
(
|
||||||||||||
| Cash and Cash Equivalents: | ||||||||||||||
| Beginning of period |
|
|
||||||||||||
| End of period | $ |
|
$ |
|
||||||||||
| Supplemental Disclosures of Non-Cash Investing and Financing Activities: | ||||||||||||||
| Capitalized software development costs recorded in accounts payable and accrued expenses and other current liabilities | $ |
|
$ |
|
||||||||||
| Supplemental Disclosures of Cash Flow Information: | ||||||||||||||
| Income tax payments | $ |
|
$ |
|
||||||||||
| Cash paid for interest |
|
|
||||||||||||
| Supplemental Cash Flow Disclosure Related to Operating Leases: | ||||||||||||||
| Cash paid for amounts included in the measurement of lease liabilities | $ |
|
$ |
|
||||||||||
|
Lease liabilities arising from obtaining right-of-use assets
|
|
|
||||||||||||
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
|||||||||||||||||||||||||
| (in millions) | 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||||
| Revenue | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Costs and Expenses: | ||||||||||||||||||||||||||
| Performance marketing |
|
|
|
|
||||||||||||||||||||||
| Brand marketing |
|
|
|
|
||||||||||||||||||||||
|
Personnel-related expenses
1
|
|
|
|
|
||||||||||||||||||||||
|
Stock-based compensation
1
|
|
|
|
|
||||||||||||||||||||||
| Capitalized internally developed software costs |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Depreciation and amortization |
|
|
|
|
||||||||||||||||||||||
|
Other segment costs and expenses
2
|
|
|
|
|
||||||||||||||||||||||
| Total costs and expenses |
|
|
|
|
||||||||||||||||||||||
|
Income from Operations
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
|||||||||||||||||||||||||
| (in millions) | 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||||
| Performance marketing | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Brand marketing |
|
|
|
|
||||||||||||||||||||||
| Organic and other marketing |
|
|
|
|
||||||||||||||||||||||
|
Total Sales and Marketing
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
|||||||||||||||||||||||||
| (in millions) | 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||||
|
Insurance
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Credit cards |
|
|
|
|
||||||||||||||||||||||
|
SMB products
|
|
|
|
|
||||||||||||||||||||||
| Loans |
|
|
|
|
||||||||||||||||||||||
|
Emerging verticals
|
|
|
|
|
||||||||||||||||||||||
|
Total Revenue
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| (in millions) |
Quoted Prices
in Active Markets (Level 1) |
Other
Observable Inputs (Level 2) |
Significant
Unobservable Inputs (Level 3) |
Total
Carrying Value |
||||||||||||||||||||||
|
As of September 30, 2025
|
||||||||||||||||||||||||||
| Assets: | ||||||||||||||||||||||||||
| Cash and cash equivalents—money market funds | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Certificate of deposit |
|
|
|
|
||||||||||||||||||||||
|
Mortgage loans held for sale
|
|
|
|
|
||||||||||||||||||||||
|
Total Assets Measured at Fair Value
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| (in millions) |
Quoted Prices
in Active Markets (Level 1) |
Other
Observable Inputs (Level 2) |
Significant
Unobservable Inputs (Level 3) |
Total
Carrying Value |
||||||||||||||||||||||
|
As of December 31, 2024
|
||||||||||||||||||||||||||
| Assets: | ||||||||||||||||||||||||||
| Cash and cash equivalents—money market funds | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Certificate of deposit |
|
|
|
|
||||||||||||||||||||||
|
Mortgage loans held for sale
|
|
|
|
|
||||||||||||||||||||||
| Total Assets Measured at Fair Value | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
|
Outstanding
Stock Options
(in thousands)
|
Weighted-Average
Exercise Price |
Weighted-Average
Remaining
Contractual Life
(in years)
|
Aggregate
Intrinsic Value
(in millions)
|
|||||||||||||||||||||||
|
Balance as of December 31, 2024
1
|
|
$ |
|
|
$ |
|
||||||||||||||||||||
|
Granted
2
|
|
$ |
|
|||||||||||||||||||||||
| Exercised |
(
|
$ |
|
|||||||||||||||||||||||
|
Cancelled/forfeited
2
|
(
|
$ |
|
|||||||||||||||||||||||
|
Balance as of September 30, 2025
1
|
|
$ |
|
|
$ |
|
||||||||||||||||||||
|
Vested and exercisable as of September 30, 2025
|
|
$ |
|
|
$ |
|
||||||||||||||||||||
|
Nine Months Ended
September 30, |
||||||||||||||
| 2025 | 2024 | |||||||||||||
| Expected volatility |
|
% |
|
% | ||||||||||
| Expected term (in years) |
|
|
||||||||||||
| Risk-free interest rate |
|
% |
|
% | ||||||||||
|
Number of Units
(in thousands)
|
Weighted-Average
Grant-Date Fair Value |
|||||||||||||
|
Nonvested as of December 31, 2024
1
|
|
$ |
|
|||||||||||
|
Granted
1
|
|
$ |
|
|||||||||||
|
Vested
1
|
(
|
$ |
|
|||||||||||
|
Forfeited
|
(
|
$ |
|
|||||||||||
|
Nonvested as of September 30, 2025
1
|
|
$ |
|
|||||||||||
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
|||||||||||||||||||||||||
| (in millions) | 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||||
| Research and development | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Sales and marketing |
|
|
|
|
||||||||||||||||||||||
| General and administrative |
|
|
|
|
||||||||||||||||||||||
|
Total Stock-based Compensation
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
|||||||||||||||||||||||||
| (in millions, except per share amounts) | 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||||
| Numerator: | ||||||||||||||||||||||||||
|
Net income (loss) attributable to common stockholders—basic and diluted
|
$ |
|
$ |
|
$ |
|
$ |
(
|
||||||||||||||||||
| Denominator: | ||||||||||||||||||||||||||
|
Weighted-average shares of common stock—basic
|
|
|
|
|
||||||||||||||||||||||
|
Effect of dilutive RSUs, stock options and ESPP shares
|
|
|
|
|
||||||||||||||||||||||
|
Weighted-average shares of common stock—diluted
|
|
|
|
|
||||||||||||||||||||||
|
Net income (loss) per share attributable to common stockholders:
|
||||||||||||||||||||||||||
| Basic | $ |
|
$ |
|
$ |
|
$ |
(
|
||||||||||||||||||
| Diluted | $ |
|
$ |
|
$ |
|
$ |
(
|
||||||||||||||||||
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
|||||||||||||||||||||||||
| (in millions) | 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||||
|
Shares subject to outstanding stock options and RSUs
|
|
|
|
|
||||||||||||||||||||||
|
ESPP
|
|
|
|
|
||||||||||||||||||||||
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
|||||||||||||||||||||||||
|
(in millions)
|
2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||||
| Revenue | $ | 215.1 | $ | 191.3 | $ | 611.2 | $ | 503.8 | ||||||||||||||||||
|
Costs and Expenses:
|
||||||||||||||||||||||||||
| Cost of revenue | 15.3 | 17.7 | 50.1 | 46.8 | ||||||||||||||||||||||
|
Research and development
1
|
15.7 | 23.0 | 50.4 | 66.4 | ||||||||||||||||||||||
|
Sales and marketing
1
|
135.3 | 128.1 | 423.0 | 342.1 | ||||||||||||||||||||||
|
General and administrative
1
|
14.4 | 15.9 | 41.9 | 47.8 | ||||||||||||||||||||||
| Total costs and expenses | 180.7 | 184.7 | 565.4 | 503.1 | ||||||||||||||||||||||
|
Income from Operations
|
34.4 | 6.6 | 45.8 | 0.7 | ||||||||||||||||||||||
| Other income, net: | ||||||||||||||||||||||||||
| Interest income | 1.0 | 1.3 | 2.5 | 4.2 | ||||||||||||||||||||||
| Interest expense | (0.2) | (0.1) | (0.5) | (0.5) | ||||||||||||||||||||||
| Other gains (losses), net | 0.3 | — | 0.5 | (0.1) | ||||||||||||||||||||||
| Total other income, net | 1.1 | 1.2 | 2.5 | 3.6 | ||||||||||||||||||||||
| Income before income taxes | 35.5 | 7.8 | 48.3 | 4.3 | ||||||||||||||||||||||
| Income tax provision | 9.2 | 7.7 | 13.6 | 12.5 | ||||||||||||||||||||||
|
Net Income (Loss)
|
$ | 26.3 | $ | 0.1 | $ | 34.7 | $ | (8.2) | ||||||||||||||||||
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
|||||||||||||||||||||||||
|
(in millions)
|
2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||||
| Research and development | $ | 2.0 | $ | 3.7 | $ | 6.6 | $ | 9.4 | ||||||||||||||||||
| Sales and marketing | 1.7 | 2.3 | 6.4 | 7.6 | ||||||||||||||||||||||
| General and administrative | 3.0 | 4.2 | 8.6 | 12.2 | ||||||||||||||||||||||
| Total stock-based compensation | $ | 6.7 | $ | 10.2 | $ | 21.6 | $ | 29.2 | ||||||||||||||||||
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
|||||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||||||
| Revenue | 100 | % | 100 | % | 100 | % | 100 | % | ||||||||||||||||||
|
Costs and Expenses:
|
||||||||||||||||||||||||||
| Cost of revenue | 7 | 10 | 8 | 9 | ||||||||||||||||||||||
| Research and development | 7 | 12 | 8 | 13 | ||||||||||||||||||||||
| Sales and marketing | 63 | 67 | 69 | 68 | ||||||||||||||||||||||
| General and administrative | 7 | 8 | 7 | 10 | ||||||||||||||||||||||
| Total costs and expenses | 84 | 97 | 92 | 100 | ||||||||||||||||||||||
|
Income from Operations
|
16 | 3 | 8 | — | ||||||||||||||||||||||
| Other income, net: | ||||||||||||||||||||||||||
| Interest income | — | 1 | — | 1 | ||||||||||||||||||||||
| Interest expense | — | — | — | — | ||||||||||||||||||||||
| Other gains (losses), net | — | — | — | — | ||||||||||||||||||||||
| Total other income, net | — | 1 | — | 1 | ||||||||||||||||||||||
| Income before income taxes | 16 | 4 | 8 | 1 | ||||||||||||||||||||||
| Income tax provision | 4 | 4 | 2 | 3 | ||||||||||||||||||||||
|
Net Income (Loss)
|
12 | % | 0 | % | 6 | % | (2 | %) | ||||||||||||||||||
|
Three Months Ended
September 30, |
Change |
Nine Months Ended
September 30, |
Change | |||||||||||||||||||||||||||||||||||||||||||||||
|
(in millions)
|
2025 | 2024 | $ | % | 2025 | 2024 | $ | % | ||||||||||||||||||||||||||||||||||||||||||
|
Insurance
|
$ | 70.9 | $ | 68.7 | $ | 2.2 | 3 | % | $ | 199.6 | $ | 119.6 | $ | 80.0 | 67 | % | ||||||||||||||||||||||||||||||||||
| Credit cards | 34.1 | 45.3 | (11.2) | (25 | %) | 106.9 | 141.4 | (34.5) | (24 | %) | ||||||||||||||||||||||||||||||||||||||||
|
SMB products
|
23.6 | 27.8 | (4.2) | (15 | %) | 77.5 | 84.3 | (6.8) | (8 | %) | ||||||||||||||||||||||||||||||||||||||||
| Loans | 39.6 | 23.8 | 15.8 | 66 | % | 91.1 | 66.9 | 24.2 | 36 | % | ||||||||||||||||||||||||||||||||||||||||
|
Emerging verticals
|
46.9 | 25.7 | 21.2 | 83 | % | 136.1 | 91.6 | 44.5 | 49 | % | ||||||||||||||||||||||||||||||||||||||||
|
Total Revenue
|
$ | 215.1 | $ | 191.3 | $ | 23.8 | 12 | % | $ | 611.2 | $ | 503.8 | $ | 107.4 | 21 | % | ||||||||||||||||||||||||||||||||||
|
Three Months Ended
September 30, |
Change |
Nine Months Ended
September 30, |
Change | |||||||||||||||||||||||||||||||||||||||||||||||
| (in millions) | 2025 | 2024 | $ | % | 2025 | 2024 | $ | % | ||||||||||||||||||||||||||||||||||||||||||
| Cost of revenue | $ | 15.3 | $ | 17.7 | $ | (2.4) | (13 | %) | $ | 50.1 | $ | 46.8 | $ | 3.3 | 7 | % | ||||||||||||||||||||||||||||||||||
| Research and development | 15.7 | 23.0 | (7.3) | (31 | %) | 50.4 | 66.4 | (16.0) | (24 | %) | ||||||||||||||||||||||||||||||||||||||||
| Sales and marketing | 135.3 | 128.1 | 7.2 | 6 | % | 423.0 | 342.1 | 80.9 | 24 | % | ||||||||||||||||||||||||||||||||||||||||
| General and administrative | 14.4 | 15.9 | (1.5) | (10 | %) | 41.9 | 47.8 | (5.9) | (12 | %) | ||||||||||||||||||||||||||||||||||||||||
|
Total Costs and Expenses
|
$ | 180.7 | $ | 184.7 | $ | (4.0) | (2 | %) | $ | 565.4 | $ | 503.1 | $ | 62.3 | 12 | % | ||||||||||||||||||||||||||||||||||
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
|||||||||||||||||||||||||||||||||||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||||||||||||||||||||||||||||||
| (in millions) |
$
|
%
|
$ |
%
|
$ |
%
|
$ |
%
|
||||||||||||||||||||||||||||||||||||||||||
| Performance marketing | $ | 104.8 | 77 | % | $ | 91.9 | 72 | % | $ | 291.9 | 69 | % | $ | 206.0 | 60 | % | ||||||||||||||||||||||||||||||||||
| Brand marketing | 5.1 | 4 | % | 11.9 | 9 | % | 54.4 | 13 | % | 57.5 | 17 | % | ||||||||||||||||||||||||||||||||||||||
| Organic and other marketing | 25.4 | 19 | % | 24.3 | 19 | % | 76.7 | 18 | % | 78.6 | 23 | % | ||||||||||||||||||||||||||||||||||||||
|
Total Sales and Marketing
|
$ | 135.3 | 100 | % | $ | 128.1 | 100 | % | $ | 423.0 | 100 | % | $ | 342.1 | 100 | % | ||||||||||||||||||||||||||||||||||
|
Three Months Ended
September 30, |
Change |
Nine Months Ended
September 30, |
Change | |||||||||||||||||||||||||||||||||||||||||||||||
| (in millions) | 2025 | 2024 | $ | % | 2025 | 2024 | $ | % | ||||||||||||||||||||||||||||||||||||||||||
| Interest income | $ | 1.0 | $ | 1.3 | $ | (0.3) | (23 | %) | $ | 2.5 | $ | 4.2 | $ | (1.7) | (41 | %) | ||||||||||||||||||||||||||||||||||
| Interest expense | (0.2) | (0.1) | (0.1) | 3 | % | (0.5) | (0.5) | — | (11 | %) | ||||||||||||||||||||||||||||||||||||||||
| Other gains (losses), net | 0.3 | — | 0.3 | 296 | % | 0.5 | (0.1) | 0.6 | NM | |||||||||||||||||||||||||||||||||||||||||
|
Total Other Income, net
|
$ | 1.1 | $ | 1.2 | $ | (0.1) | (10 | %) | $ | 2.5 | $ | 3.6 | $ | (1.1) | (31 | %) | ||||||||||||||||||||||||||||||||||
|
Three Months Ended
September 30, |
Nine Months Ended
September 30, |
|||||||||||||||||||||||||
| (in millions) | 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||||
|
Income from Operations
|
$ | 34.4 | $ | 6.6 | $ | 45.8 | $ | 0.7 | ||||||||||||||||||
| Depreciation and amortization | 11.6 | 12.9 | 36.9 | 37.0 | ||||||||||||||||||||||
| Acquisition-related retention | — | 0.8 | 1.6 | 3.3 | ||||||||||||||||||||||
|
Acquisition-related expenses
|
0.9 | 0.5 | 1.7 | 0.6 | ||||||||||||||||||||||
|
Loss on disposal of assets
|
— | — | 0.3 | — | ||||||||||||||||||||||
|
Restructuring
|
— | 7.8 | 0.4 | 7.8 | ||||||||||||||||||||||
| Capitalized internally developed software costs | (5.6) | (5.7) | (15.4) | (18.6) | ||||||||||||||||||||||
|
Non-GAAP Operating Income
|
$ | 41.3 | $ | 22.9 | $ | 71.3 | $ | 30.8 | ||||||||||||||||||
|
Operating income margin
|
16 | % | 3 | % | 7 | % | 0 | % | ||||||||||||||||||
|
Non-GAAP operating income margin
1
|
19 | % | 12 | % | 12 | % | 6 | % | ||||||||||||||||||
|
Net Income (Loss)
|
$ | 26.3 | $ | 0.1 | $ | 34.7 | $ | (8.2) | ||||||||||||||||||
| Depreciation and amortization | 11.6 | 12.9 | 36.9 | 37.0 | ||||||||||||||||||||||
| Stock-based compensation | 6.7 | 8.7 | 21.6 | 27.7 | ||||||||||||||||||||||
| Acquisition-related retention | — | 0.8 | 1.6 | 3.3 | ||||||||||||||||||||||
|
Acquisition-related expenses
|
0.9 | 0.5 | 1.7 | 0.6 | ||||||||||||||||||||||
| Loss on disposal of assets | — | — | 0.3 | — | ||||||||||||||||||||||
|
Restructuring
|
— | 7.8 | 0.4 | 7.8 | ||||||||||||||||||||||
|
Interest income, net
|
(0.8) | (1.2) | (2.0) | (3.7) | ||||||||||||||||||||||
|
Other (gains) losses, net
|
(0.3) | — | (0.5) | 0.1 | ||||||||||||||||||||||
|
Income tax provision
|
9.2 | 7.7 | 13.6 | 12.5 | ||||||||||||||||||||||
| Adjusted EBITDA | $ | 53.6 | $ | 37.3 | $ | 108.3 | $ | 77.1 | ||||||||||||||||||
| Stock-based compensation | (6.7) | (8.7) | (21.6) | (27.7) | ||||||||||||||||||||||
| Capitalized internally developed software costs | (5.6) | (5.7) | (15.4) | (18.6) | ||||||||||||||||||||||
|
Non-GAAP Operating Income
|
$ | 41.3 | $ | 22.9 | $ | 71.3 | $ | 30.8 | ||||||||||||||||||
|
Net income (loss) margin
|
12 | % | 0 | % | 6 | % | (2 | %) | ||||||||||||||||||
|
Adjusted EBITDA margin
2
|
25 | % | 19 | % | 18 | % | 15 | % | ||||||||||||||||||
|
Nine Months Ended
September 30, |
||||||||||||||
| (in millions) | 2025 | 2024 | ||||||||||||
| Net cash provided by operating activities | $ | 92.7 | $ | 61.9 | ||||||||||
| Net cash used in investing activities | (20.4) | (24.4) | ||||||||||||
| Net cash used in financing activities | (17.7) | (66.3) | ||||||||||||
|
Effect of exchange rate changes on cash and cash equivalents
|
(0.3) | 0.1 | ||||||||||||
| Net increase (decrease) in cash and cash equivalents | $ | 54.3 | $ | (28.7) | ||||||||||
| Period |
Total Number of Shares Purchased
1
(in thousands)
|
Average Price Paid per Share
2
|
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
1
(in thousands)
|
Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs
1
(in millions)
|
||||||||||||||||||||||
| July 1, 2025 - July 31, 2025 | — | $ | — | — | $ | 25.0 | ||||||||||||||||||||
| August 1, 2025 - August 31, 2025 | 298 | $ | 9.94 | 298 | $ | 22.0 | ||||||||||||||||||||
| September 1, 2025 - September 30, 2025 | 1,484 | $ | 10.95 | 1,484 | $ | 55.8 | ||||||||||||||||||||
| Total | 1,782 | 1,782 | ||||||||||||||||||||||||
|
Exhibit
Number
|
Description of Exhibit
|
Location
|
||||||||||||
| 31.1 | Filed herewith | |||||||||||||
| 31.2 | Filed herewith | |||||||||||||
|
32.1*
|
Furnished herewith | |||||||||||||
|
32.2*
|
Furnished herewith | |||||||||||||
| 101.INS |
Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).
|
**
|
||||||||||||
| 101.SCH |
Inline XBRL Taxonomy Extension Schema Document.
|
**
|
||||||||||||
| 101.CAL |
Inline XBRL Taxonomy Extension Calculation Linkbase Document.
|
**
|
||||||||||||
| 101.DEF |
Inline XBRL Taxonomy Extension Definition Linkbase Document.
|
**
|
||||||||||||
| 101.LAB |
Inline XBRL Taxonomy Extension Label Linkbase Document.
|
**
|
||||||||||||
| 101.PRE |
Inline XBRL Taxonomy Extension Presentation Linkbase Document.
|
**
|
||||||||||||
| 104 |
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibits 101).
|
**
|
||||||||||||
| NERDWALLET, INC. | ||||||||||||||
|
Date:
|
November 6, 2025 | By: |
/s/ Jun Hyung Lee
|
|||||||||||
|
Jun Hyung Lee
|
||||||||||||||
| Chief Financial Officer | ||||||||||||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|